How Seniors Can Truly Benefit from Low-Impact Workouts
Activity is vital at any life stage. It helps children develop correctly, keeps adults healthy and reduces the impact of old age in seniors. Elders that stay active can enjoy various benefits to their well-being, even from low-impact workouts.
Still, it isn’t always easy to keep motivated to work out, especially during these hot summer days. To avoid loss of motivation, seniors should always keep in mind how beneficial exercise can be for them. Let’s have a look at how seniors can genuinely benefit from low-impact workouts, as well as what the best low-impact workouts are.
Better Mental Health
Whichever form of exercise you choose, it’s sure to produce endorphins. Activities in nature will further increase the impact of the “feel good” hormone, ensuring you’ll feel satisfied and happy afterward. Nature walks or hikes, cycling, and yoga can serve you well in reducing bad moods and improve your overall mental health. Exercise has an exceptionally positive impact on insomnia and other sleeping problems, which are common in seniors.
Better Physical Health
Regular activity prevents or lowers the risk of many illnesses, and keeps your body strong and healthy. Working out improves our immune system, which is especially crucial for elders since they are more vulnerable to diseases. But low-impact workouts don’t only keep diseases at bay. They also reduce the risk of falling by improving strength, flexibility, balance, and coordination. Even the most basic low-impact exercise like walking can help, as long as it’s done regularly.
More Social Engagement
One of the best things about exercise is that it doesn’t have to be a solitary activity. Like-minded seniors can get together for walks or hiking. Having company usually improves accountability as well, so you’ll be more motivated to keep up with your workout habits. Another right way to stay active while enjoying company, is signing up for dancing or a fitness class. By maintaining social ties, you’ll keep loneliness at bay as well.
Improved Brain Function
According to multiple studies, physical activity also has a positive influence on our cognitive function. Exercise improves and fine-tunes our motor skills, which in turn keeps our mind sharp. Active seniors are in less of a risk from dementia, regardless of whether they’ve always been active or not. What matters is that you stay physically active.
Best Low-Impact Exercises
Sometimes seniors can find the idea of exercise intimidating due to fear of falling or injury. It is precisely why low-impact workouts are recommended as they are relatively easy compared to full-blown workout routines. Walking is the easiest one to get into but provides a full-body workout. The same goes for swimming, which is considered to be one of the safest solutions for exercising when joint health is in question. Stretching and yoga are great for building flexibility and balance or maintaining them in old age. Alternatively, you might want to take up cycling, dancing or tai chi.
Ultimately, staying active is one of the best ways to ensure a good quality of life even if you’re well into your senior years. And if you’re experiencing any orthopaedic problems, professionals at Florida Orthopaedic Institute are here to help. Schedule an appointment today to start feeling better tomorrow.
Elizabeth Domenech, national strategies pr
Office: (813) 865-3093 I Mobile: (787) 587-3213
3030 North Rocky Point Drive West, Suite 150, Tampa, FL 33607
Confidential: This electronic message and all contents contain information from National Strategies Public Relations which may be privileged, confidential or otherwise protected from disclosure. The information is intended to be for the addressee only. If you are not the addressee, any disclosure, copy, distribution or use of the contents of this message is prohibited. If you have received this electronic message in error, please notify the sender and destroy the original message and all copies.
If you would rather not receive future communications from Florida Orthopaedic Institute, let us know by clicking here.
Florida Orthopaedic Institute, 909 N. Dale Mabry Hwy, Suite 201 Suite 201, Tampa, Florida 33609 United States
" src="blob:http://www.trainitright.com/2c02cb70-4310-4679-84c7-859ba61510e8" alt="Christopher Grayson M.D..jpg" type="application/x-apple-msg-attachment" class="Apple-web-attachment Singleton" style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; font-family: Helvetica; font-size: 12px;">
Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
LAVAL, QC and WELLESLEY, MA, Sept. 4, 2018 /CNW Telbec/ - Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.

NEOMED-LABS is a leading provider of clinical immunology laboratory services for biologics drug development, with extensive experience supporting the development of novel vaccines. Formed in April 2015 as a spin-out from GSK's Clinical Laboratory Services unit, NEOMED-LABS has built on its world-renowned expertise in clinical immunology to form partnerships with many of the top 10 global vaccine developers, innovative biotechnology companies, and prestigious governmental and non-governmental organizations. Ampersand's investment positions NEOMED-LABS to pursue both organic and acquisition-related growth initiatives, including expansion into adjacent markets and geographies as well as to continue to expand its presence in Quebec.
"After a successful spin-out from GSK and strong business performance during its first three years of operation, this investment from Ampersand will help NEOMED-LABS achieve the next level in its evolution and support the growing needs of our customers," said Benoit Bouche, President and Chief Executive Officer of NEOMED-LABS. "We are extremely pleased to enter into this new partnership with Ampersand, given their unique experience in helping laboratory-based pharmaceutical services companies like NEOMED-LABS grow. Their strategic insights will undoubtfully help us continue fueling our rapid growth trajectory, broaden our customer base and pursue our international expansion."
"We are excited to partner with Benoit Bouche and his team at NEOMED-LABS" stated Eric Lev, Partner at Ampersand. "We believe NEOMED-LABS has tremendous potential in the clinical immunology field. Our goal is to actively support management to build the company into the world class leader of immunology-related assay development and clinical trial laboratory services."
Donald Olds, President and CEO of the NEOMED Institute added: "I am very pleased with the closing of this strategic transaction. The NEOMED Institute formed NEOMED-LABS in 2015 to preserve over 50 high paying R&D positions in Quebec and we have accomplished our mission. This transaction positions NEOMED-LABS for future success through access to new capital and the international network and expertise of Ampersand. I am highly confident that this new partnership will lead to significant future business and employment growth for the benefit of the Quebec and Canadian life sciences industry, which is a core objective of the NEOMED Institute."
ABOUT NEOMED-LABS
NEOMED-LABS is a leading, independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.
For more information, please visit: www.neomedlabs.com
ABOUT AMPERSAND CAPITAL PARTNERS
Founded in 1988, Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of our core healthcare sectors, including Brammer Bio, Confluent Medical, Genewiz, Genoptix, Talecris Biotherapeutics and Viracor-IBT Laboratories.
For more information, please visit: www.ampersandcapital.com
ABOUT THE NEOMED INSTITUTE
The NEOMED Institute is a successful and innovative Canadian not-for-profit R&D organization whose mission is to enable and accelerate the commercialization of life science discoveries. NEOMED Institute operates two complementary and integrated divisions: NEOMED Therapeutics in-licenses promising scientific discoveries from Canadian university centres and research institutes and then funds and develops these programs to stages that are attractive for partnering or stand-alone financing; and NEOMED Innovation Centre operates a world-class life sciences ecosystem in Montreal, Quebec hosting 30 life sciences companies employing over 350 people who operate in our two state-of-the-art R&D centres. The NEOMED Institute is funded by pharmaceutical partners, Quebec's Ministry of the Economy of Science and Innovation, and the Networks of Centres of Excellence of Canada.
For more information, please visit: www.neomed.ca
SOURCE NEOMED-LABS Inc.
Baxter announces Health Canada approval of OLIMEL 7.6% high protein Parenteral Nutrition formulations
- Highest protein and lowest glucose formulation among Parenteral Nutrition (PN) products (with or without electrolytes) available in a standardized, triple-chamber bag1,2,3,4
- New PN formulation will help meet needs of high stress patients who require more protein and are often impacted by hyperglycemia
- OLIMEL 7.6% and 7.6% E are the latest additions to Baxter's olive oil-based parenteral nutrition portfolio
MISSISSAUGA, ON, Sept. 4, 2018 /CNW/ - Baxter Canada, a leader in nutrition therapy, today announced Health Canada approval of OLIMEL 7.6% and OLIMEL 7.6% E (amino acids, dextrose, lipids with/without electrolytes, injectable emulsion) for parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated. These OLIMEL 7.6% nutrition solutions are the latest additions to the company's olive oil-based parenteral nutrition portfolio. As a ready-to-use solution, OLIMEL 7.6% (with or without electrolytes) is designed to meet the needs of high-risk patients by combining the highest protein with the lowest glucose formulation available in a standardized, triple-chamber bag.

Critically-ill patients and those who have major surgery may require parenteral nutrition, which may be necessary when a patient cannot get adequate nutrients orally or through tube feeding. Most of these patients receive less than half of the protein that is recommended for more than 10 days in the ICU5. While recent studies show that higher protein treatments were associated with lower mortality rates in the ICU6,7 giving patients more protein with ready-to-use products can have the unintended consequence of increasing their intake of glucose and potentially lead to overfeeding.
"Through our focus on innovation, Baxter is able to bring OLIMEL 7.6% and OLIMEL 7.6% E, our latest parenteral nutrition products, to Canadian hospitals," said James Teaff, Business Unit Head, Hospital Products. "Clinicians now have two new nutritional solutions to help their adult patients reach their protein targets, regain their health sooner and minimize hospital stays."
Baxter's latest OLIMEL 7.6% formulations provide clinicians new options for treating critically-ill patients, as they include:
- 76g of protein (amino acid) per liter, designed to deliver protein targets in lower fluid volumes.
- Only 73g of glucose per liter which helps reduce the risk of hyperglycemia.
- Olive oil-based lipid emulsions that may preserve immune function 8,9,10,11,12.
The use of high protein regimens and olive oil-based lipid emulsions are supported by ASPEN guidelines.
Consult the OLIMEL product monograph at: http://www.baxter.ca/en_CA/assets/downloads/monographs/OLIMEL_EN.pdf
for contraindications, warnings, precautions, adverse reactions, interactions, dosing, and conditions of clinical use. The product monograph is also available through the Baxter medical department.
About Baxter Canada
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For over 80 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Baxter Canada and its nearly 1,000 employees are located primarily in Ontario at the Head Office, CIVA Admixing and Technical Services Centres in Mississauga, and in Alliston – where Baxter operates Canada's only large scale manufacturing plant producing life-sustaining intravenous and dialysis solutions. To learn more, visit www.baxter.ca and follow us on Twitter, LinkedIn and Facebook.
Baxter and OLIMEL are registered trademarks of Baxter International Inc.
| __________________________ |
| 1 |
OLIMEL N12 SmPC, 2017. |
| 2 |
SmofKabiven SmPC, 2017. |
| 3 |
NutriFlex SmPC, 2015. |
| 4 |
Trimix HP SmPC, 2017. |
| 5 |
Hoffer and Bistrian. Am J Clin Nutr 2012;96:591–600. |
| 6 |
Elke G et al. Critical Care 2014;18:R29. |
| 7 |
Allingstrup Clinical Nutrition 2012;32: 460=18. |
| 8 |
Jia Nutrition Journal 2015;14-119. |
| 9 |
Calder PC, et al. Intensive Care Med 2010;36:735-49. |
| 10 |
Granato D, et al. JPEN J Parenter Enteral Nutr 2000;24:113-8. |
| 11 |
Olthof E, et al. Clin Nutr 2013;32:643-649. 4. Pontes-Arruda A, Clin Nutr Suppl 2009;4:19-23. 5. |
| 12 |
Waitzberg DL, et al. JPEN J Parenter Enteral Nutr 2006;30:351-67. |
SOURCE Baxter Corporation
Sunstar Supports Release of Chairside Guide on Prevention and Treatment of Oral Cancer
BUENOS AIRES, Sept. 3, 2018 /CNW/ - Sunstar is proud to announce the launch of Oral Cancer: Prevention and patient management, an FDI World Dental Federation chairside guide for oral health professionals. The guide is supported by Sunstar and aims to mitigate the effects of oral cancer by promoting comprehensive oral cancer screenings as an integral part of routine dental check-ups. It highlights the most common risk factors for oral cancer and underlines the importance of early diagnosis and treatment by providing practical solutions for the care pathway.
The guide was released today at the FDI World Dental Congress in Buenos Aires, Argentina. "FDI recognizes that oral health professionals play an essential role in combatting oral cancer," said Dr Kathryn Kell, FDI President. "Oral cancer is among the 10 most common cancers worldwide, but oral health professionals can help diminish its effects through early detection and swift treatment action."
The chairside guide provides oral health professionals with concise, yet comprehensive, information about oral cancer prevention, risk factors and management, and also helps them navigate the clinical examination and diagnosis through a decision tree. It focuses on the most common sites of oral cancer: the tongue, the insides of the cheeks, and the floor of the mouth.
"At Sunstar, we constantly investigate the power of a holistic approach to health to prevent and treat life-threatening conditions as early as possible. This chairside guide is a great example of a tool that supports health professionals in their daily patient screenings. Dental check-ups can be the perfect setting for early detection of several diseases, providing a central prevention role to dental professionals," said Dr Marzia Massignani, Sr Manager of Scientific Affairs at Sunstar.
Survival rates for oral cancer can be improved through early detection. Therefore, it is essential that oral health professionals such as dentists, dental hygienists, dental therapists and oral health therapists understand the importance of conducting a thorough oral screening examination for malignant and potentially malignant lesions as part of their routine clinical assessments, even in younger populations considered at lower risk for oral cancer. The chairside guide encourages and facilitates the integration of this examination into routine dental check-ups.
"About 500,000 new cases of oral and oropharyngeal cancers are diagnosed annually, three-quarters of which occur in the developing world," said Dr Ihsane Ben Yahya, FDI Council member and oral cancer expert. "FDI is committed to reducing the oral disease burden and improving oral health outcomes worldwide. By designing an informative tool to prevent,promptly detect and treat oral cancer, we act in line with our mission to lead the world to optimal oral health."
Oral Cancer: Prevention and patient management is available to consult and download on the Sunstar GUM website, and print copies in English and Spanish will be distributed at the FDI World Dental Congress at the Sunstar booth in Buenos Aires, Argentina.
About Sunstar
With an eye to the future, Sunstar's vision is to pioneer a new era of innovation, champion new invigorating partnerships, and speak to the heart of a new generation of global consumers. We strive to help people everywhere achieve better health and enhance their quality-of-life through our products and services. Based on our corporate motto "Always strive to help people everywhere achieve better health and enhance their quality-of-life", the Sunstar Group will continue to be attentive and responsive to the varied needs and expectations of our global consumers. http://www.sunstar.com/company/philosophy
About FDI World Dental Federation
FDI World Dental Federation is an international, membership-based organization that serves as the main representative body for more than 1 million dentists worldwide, active in some 200 National Dental Associations (NDAs) and specialist groups in close to 130 countries. FDI has a bold vision: to lead the world to optimal oral health. Speaking as the unified voice of dentistry, we collaborate closely with our members, oral health experts, allied health professionals, and industry partners alike to achieve this vision together. http://www.fdiworlddental.org; http://www.facebook.com/FDIWorldDentalFederation; http://www.twitter.com/fdiworlddental
SOURCE Sunstar
Hey Guys! What's new with Alicia?

BUSINESS
It has been a while since I have touched base with a personal blog. A quick summary. I am now focusing my main work load to my online train it right clients. So if you are interested in competition prep, off season, transformation or diet/lifestyle online programming don't be afraid to contact me www.trainitright.com/contact I am taking on new clients right now. For more information on online training with me you can visit: www.trainitright.com/programs
ALICIAS COMPETITION PREP
No Alicia still doesn't have her pro card. After Arnolds I felt a tad defeated and it took me a while to get into the groove of prep for Toronto. Once I did I was in it to win it. I won my class and narrowly missed that elusive pro card in the Overall. It was heart breaking. Again it took me a while to get into the swing of things for prep for Vancouver. That was a show I should have never done. Financially, mentally, physically. Although we made some insane improvements to my legs I did not bring the conditioning that I know I am capable of. After returning from Vancouver some personal drama went on. I was under a lot of stress. My cortisol was ridiculously high. I know this because of my mental state, events that were happening and the fact I did not it like an @$$ hole but completely lost my conditioning. I decided not to do North Americans. A show immediately after Vancouver that I had my eyes on. I thought about doing the Amateur Olympia but again I want to bring my absolute best that I know I am capable. And this time I have something to prove. I also want to silence the "Alicia Bell haters." Having haters is fine by me. It means I am doing something right. But Im going after the Toronto October show with everything that I have to give! Lets do the damn thing people! Im in it to win it. I want to have people stop and be like WTF happened with Alicia she looks insane. And that is when I know I will be ready. If you want to keep more up to date with whats going on please go like and subscribe to my Youtube: www.youtube.com/trainitright The more people do things to hurt me the deeper my passion and drive gets to succeed! So thank you for all that you have done for me.
Thanks for your on going support guys!
Happy long weekend!
Young Woman's Powerful Story Encourages Others That They Can Turn A Bad Start In Life Into Something Positive
Raleigh, NC, August 31, 2018 ― Deja' was dealt a losing hand, and no one would have blamed her for simply accepting her fate. Her father died before she was born, and her mother chose drug addiction over her daughter. With loneliness consuming her, Deja' could have folded. Should have folded. But instead, she learned how to recycle her pain, and she began drawing from every source of positive influence that entered her life: a God-loving grandmother, a supportive godmother and a street-savvy godfather who taught her how to redirect her pain and survive in this world.
But the challenges just kept coming, and Deja' encountered countless betrayals and abuses along the way, which lead to an unhealthy marriage, and ultimately, a pattern of unhealthy relationships with men that lasted for several years. Aware that she is repeating a family cycle of poor choices, Deja' needs to rally what's left of her strength and determination to break that cycle. Will her fortitude be enough? Or will this final test break her spirit once and for all?
Overcoming the Hand You Were Dealt is the powerful new book from Kisha Taylor. Cultivated from her personal experience with abandonment, Overcoming weaves an authentic and captivating story of struggle, pain, hope and faith that culminates in a heartwarming climax of healing and restoration.
In addition to the book, Taylor's website, lifeunlimited1.com, enables her to continue her passion for women's emotional health, with courses that tap into the warrior in every woman, that cover abandonment issues and that help survivors understand why they act and feel the way they do. The website also houses inspirational items like T-shirts and mugs with messages of empowerment, and a blog with videos and messages of encouragement.
Author Kisha Taylor was born in Brooklyn, NY, and from a young age she learned how to navigate the real world of hard knocks. She attended Binghamton University and Baruch College, where she studied accounting and psychology. She became counsel to many, sharing principles on surviving abuse, overcoming life's challenges, healthy ways of handling personal mistakes and how to not surrender to self-defeat.
She is most proud of the lives her journey has impacted, as well as the happiness, confidence and emotional health she now has, which enables her to be a testament of, "You can, if you just don't give up.”
To read more about Taylor, or to view her motivational videos, please visit: www.lifeunlimited1.com/blog, https://bit.ly/2uLrQWT, or https://www.youtube.com/watch?v=fSfBxoyOLsk.
Overcoming the Hand You Were Dealt
Pendium publishing
Released: 2018
ISBN-10: 1944348409
ISBN-13: 978-1944348403
Available at www.lifeunlimited1.com, Amazon.com, and all other online outlets.
| Flexitarian diet is on trend as nearly one-quarter of the global population follows a low meat diet, says GlobalData
Consumers are reducing the amount of meat in their daily consumption and are instead exploring niche areas of the human diet, including trying a different combination of culinary inputs, according to GlobalData, a leading data and analytics company.
According to GlobalData’s 2017 Q1 global consumer survey, nearly one-quarter (23%) of the global population stated they follow a low meat diet when asked to describe their daily diet. This suggests that the flexitarian diet is on trend, proving to be the most popular diet among consumers globally.

IMAGE FOR PUBLICATION: Percentage of global consumers who are on the following diets
Charles Sissens, Consumer Analyst at GlobalData, says: “Brands within the FMCG community must take it upon themselves to cater for lower levels and/or less frequent meat consumption, and promote the direct benefits associated with a flexitarian diet. More importantly, brands should accommodate these changes by re-formulating new product development to include more plant-based inputs, including fruit, vegetables and nuts.”
Californian fast-food chain Plant Power offers consumers traditional meaty meals, such as burger and fries, albeit made 100% from plants. The company highlights their strong health appeal: entirely cholesterol free, 100% GMO free and nothing artificial.
Sissens concludes: “If leading chains such as McDonald’s and Burger King can mirror similar tactics, it will increase the availability of plant-based consumption, thus aligning to the growing trend.”
GlobalData.com | Facebook | LinkedIn | Twitter
About GlobalData
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors. |
|

Fashion Talks™ reveals full schedule at Toronto Fashion Week®
TORONTO, ON — The countdown is on as
Toronto Fashion Week®, in collaboration with
RE\SET™, is only days away. The three-day long event proudly shares an extended schedule for
Fashion Talks™, taking place
Sept. 4-6.
The live taping of the Fashion Talks™ podcast, hosted by Donna Bishop in the RE\SET™ Studio (upper level of Yorkville Village, 136 Yorkville Ave.) will see her chat with some of the most recognizable faces in fashion, film, television and photography to share their stories in an intimate studio setting. Guests will reveal insights, observations and historical moments on how fashion helps to shape the world in which we live in and how our world shapes fashion and the clothing we wear.
Kicking off Fashion Talks at Toronto Fashion Week on Sept. 4 is Elizabeth Peyton-Jones (fashion activist and founder of the Responsible Trust for Models) about her work within the fashion and modelling industry to protect, educate and empower young models. On Sept. 5, starting at 2 PM, a double header will see Canada’s leading film and television costume designers from The Canadian Alliance of Film & Television Costume Arts & Design (CAFTCAD) discuss the process and power of custom design and the upcoming exhibit From Concept to Creation (Sept. 4-30 at Yorkville Village), followed by an engaging discussion with Caitlin Cronenberg and Jessica Ennis (photographer and production designer), about the power of fashion in their new book The Endings: Photographic Stories of Love, Loss, Heartbreak and Beginning Again.
At 2:30 PM on Sept. 6, Donna is joined by the cast of the new fashion competition series STITCHED, host and fashion model Kim Cloutier (@cloutierkim) and resident judges, style expert Joe Zee (@mrjoezee) and ELLE Canada’s Editor-in-Chief Vanessa Craft(@vanessacraft). Premiering Sept. 9 at 9 p.m. ET/PT on Slice, STITCHED is the stylish competition series where skilled fashion designers match wits and stitches in an epic fashion throw-down, facing off in dramatic themed challenges. Rounding out the last day of Toronto Fashion Week, Dr. Alexandra Palmer (Nora E. Vaughan Senior Curator, Textiles and Costume at the Royal Ontario Museum) will speak to guests about the importance of fashion and textile collections for museums and for its visitors.
Check your inbox daily for updates on events happening from Sept. 4 to Sept. 6 and for event recaps. Tickets are now on sale at TFW.to.
To RSVP to Fashion Talks™ or for more information about Toronto Fashion Week, please contact:
Kelly MacDonald, rock-it promotions, inc., at kelly@rockitpromo.com or 416.656.0707 ext. 129
Daliah Marsons, rock-it promotions, inc., at daliah@rockitpromo.com or 416.656.0707 ext. 109
Tuesday, September 4
3:00 PM | Fashion Talks | RE\SET™ Studio | Contact: hello@fashiontalks.ca
In Conversation with Fashion Activist Elizabeth Peyton-Jones, founder of the Responsible Trust for Models, an international organization dedicated to revolutionizing the modelling industry
Wednesday, September 5
2:00 PM | Fashion Talks | RE\SET™ Studio | Contact: hello@fashiontalks.ca
In Conversation with Canada’s leading film and television costume designers on the process and power of costume design.
3:00 PM | Fashion Talks | RE\SET™ Studio | Contact: hello@fashiontalks.ca
In Conversation with Caitlin Cronenberg and Jessica Ennis on the power of fashion in their book The Endings: Photographic Stories of Love, Loss, Heartbreak, and Beginning Again
*This Fashion Talks taping will be followed by a book signing with Cronenberg and Ennis
Thursday, September 6
2:30 PM | Fashion Talks | RE\SET™ Studio | Contact: hello@fashiontalks.ca
In Conversation with STITCHED cast, host and fashion model Kim Cloutier and resident judges, style expert Joe Zee and ELLE Canada’s Editor-in-Chief Vanessa Craft on how media content democratizes fashion
4:30 PM | Fashion Talks | RE\SET™ Studio | Contact: hello@fashiontalks.ca
In Conversation with Dr. Alexandra Palmer, Nora E. Vaughan Senior Curator, Textiles and Costume at the Royal Ontario Museum on the importance of Fashion and Textile collections for Museums and for its visitors. The ROM holds the largest collection of fashion and textiles in Canada and is the third largest in the world
ABOUT TORONTO FASHION WEEK®
Toronto Fashion Week®, an event showcasing fashion, art, music and culture takes place in Yorkville, Toronto’s revitalized and most prestigious luxury retail neighborhood. The bi-annual event hosts national and international designers, entertainers and the fashion community to create a touchpoint where fashion is embraced and celebrated. As the leading fashion event in Canada, Toronto Fashion Week creates a catalyst for media engagement, retail activity and global connectivity.
The founding partners are Yorkville Village, The Hazelton Hotel, Freed Developments and Hill & Gertner – an ownership group comprised of several of the country's top companies in real estate, development and luxury hospitality.
Website: TFW.to
Instagram: @tfw
Twitter: @tofashionwk
Facebook: @tofashionwk
Hashtag: #tofw
ABOUT FASHION TALKS™
Fashion Talks™ is the podcast that observes the world through the lens of fashion. Founded in 2017, creator and host Donna Bishop interviews designers, stylists, academics, industry insiders and leaders outside of the fashion industry to reveal insights, observations, personal stories and historical moments on how fashion helps to shape the world we live in and how our world shapes fashion and the clothes we wear. Fashion Talks™ is available for download on Apple Podcasts, Stitcher and to stream at fashiontalks.ca. While the majority of listeners are from Canada and the US, Fashion Talks boasts regular listeners from Japan, Germany, France, Italy and the UK. Proudly produced in partnership with CAFA, Fashion Talks™ strives to shine a spotlight on the cultural relevance of fashion while highlighting the rich expanse of the Canadian industry.
Website: fashiontalks.ca
Instagram: @fashiontalkspodcast
Facebook: /fashiontalkspodcast
Hastags: #fashiontalks
Servier finalises acquisition of Shire's oncology branch
PARIS, Aug. 31, 2018 /CNW Telbec/ - Servier, an independent international pharmaceutical company, announced today that it has finalized the previously announced acquisition of Shire's oncology branch after obtaining regulatory clearance. The 2.4 billion dollar transaction will enable Servier to establish a direct commercial presence in the United States and strengthen its oncology drug portfolio in the countries in which the Group is already present.
Servier acquires Shire's oncology business including two marketed products, ONCASPAR® 1 and ONIVYDE® 2, in addition to two collaborations currently being developed in the immuno-oncology field.
"This acquisition is a major step in achieving the Servier group's ambition", declared Olivier Laureau, President of Servier. "It marks the launch of Servier's commercial activities in the world's largest pharmaceutical market - the United States - and significantly strengthens its portfolio of oncology drugs. It is part of Servier's twofold strategy: to continue to treat an increasing number of patients with innovative medications across the world and become a world reference in oncology."
In the United States, Servier products will be marketed by the Group's new subsidiary, Servier Pharmaceuticals LLC (Boston), which is made up of 80 people, including those employees transitioning from Shire to Servier. Servier Pharmaceuticals will be led by David K. Lee who previously led Shire's Global Genetic Diseases and Oncology franchises. The subsidiary will continue to market ONCASPAR® in the United States. Servier Pharmaceuticals' twofold aim is to develop a strong sales presence in the United States, based on Servier's existing portfolio, and to enrich the portfolio with close-to-market or marketed innovative products, in accordance with the Group's strategy.
Outside the United States, approximately 75 employees from Shire are expected to integrate into Servier's organizational structure. They will continue to market ONCASPAR®and ONIVYDE® according to local legislation.
With this acquisition, Servier takes another step toward its strategic ambition to become a global biopharmaceutical company.
About Servier
Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 149 countries and a turnover of 4.152 billion euros in 2017, Servier employs 21,700 people worldwide. Entirely independent, the Group reinvests 25% of its turnover (excluding generic drugs) in research and development and uses all its profits for development. Corporate growth is driven by Servier's constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs. Servier also offers eHealth solutions beyond drug development.
More information: www.servier.com
Follow us on Social Media:
https://www.linkedin.com/company/servier/
https://www.facebook.com/Servier/
https://twitter.com/servier
________________________
At Nearly 90, This Inspiring Man Shares Wisdom And Life Experiences We Can All Learn From
Pelham, NH, August 30, 2018 ― The story of Dr. Titus Plomaritis reads like a pitch for a Hollywood movie. The third of seven children born to Greek immigrants in Lowell, Mass., during the Great Depression, Plomaritis had to work on a chicken farm at age 12 to help support his family. From there, through pure gut determination and nose to the grindstone focus, he went on to make his mark on the football fields of his high school and college alma maters; serve his country as a US Army paratrooper; excel in the world of business; and become a highly respected doctor whose insight was sought out by President Jimmy Carter. From start to finish, this is a remarkable story of achieving the American dream. This is the story of Titus. And every word of it is true.
Titus is a nostalgia-filled autobiography packed cover to cover with remarkable memories and 250 photos — many from the White House — that support the motivational stories throughout the memoir. Plomaritis and Sam Weisberg, who was associated with the Lowell Sun for 60 years as a writer, librarian and Sunday sports editor, collaborated to write Titus. Winner of the Pete Delohery Award for Best Sports Book in the 2018 Shelf Unbound Indie Book Competition, Titus is an inspirational tale for young and old and everyone in between.
Author Titus Plomaritis was born in 1929 and became a living legend in Lowell, Mass., after leading the Lowell High School football team to its first undefeated season. Plomaritis would later play four seasons at Boston University. He served as a US Army paratrooper during the early post World War II occupation of Japan. He earned a doctor of chiropractic degree from the Chiropractic Institute of New York in 1957 and a master of science in nutrition from the University of Bridgeport in Bridgeport, Conn., in 1979. Plomaritis was a fulltime practicing chiropractor for over forty years.
He established the Plomaritis Family Foundation in 2012, which has funded over $70,000 in college scholarships for students graduating from Lowell and Pelham high schools. In addition, Plomaritis recently established a perpetual scholarship at Boston University. Plomaritis and his high school sweetheart, Claire, were married for sixty-five remarkable years and had four children.
Absolutely every dollar from the sale of Titus goes directly to the Plomaritis Family Foundation to scholarships for deserving students.
For more information, please visit http://titusplomaritis.com/.
Titus
Publisher: AuthorHouse
ISBN-10: 1477271392
ISBN-13: 978-1477271391
Available from Amazon.com, Barnesandnoble.com, Authorhouse, Boston University Book Store, Lowell High School Book Store, and National University of Health Sciences Book Store